Nephros, Inc.
Price Action
Technical Summary
CONSOLIDATINGNephros, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 13), showing significant lag compared to the market leaders. Earnings contraction of 81% provides fundamental context to the price action. Investors should exercise caution due to high volatility (103% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.05 | +5.91% | ABOVE |
| 50 SMA | $3.21 | +0.53% | ABOVE |
| 100 SMA | $3.86 | -16.26% | BELOW |
| 150 SMA | $4.29 | -24.78% | BELOW |
| 200 SMA | $4.22 | -23.45% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NEPH in an uptrend right now?
NEPH has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is NEPH overbought or oversold?
NEPH's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is NEPH outperforming the market?
NEPH has a Relative Strength (RS) Rating of 13 out of 99. NEPH is currently lagging the broader market.
Where is NEPH in its 52-week range?
NEPH is trading at $3.23, which is 50% of its 52-week high ($6.42) and 30% above its 52-week low ($1.88).
How volatile is NEPH?
NEPH has a Beta of 0.59 and 52-week volatility of 103%. It's less volatile than the S&P 500 - generally more stable.